Producing clear medical images are the target of every radiologist and radiology 
technician. Images without artifacts mean better chance of appropriate diagnosis, especially for critical conditions such as diagnosing breast cancer from mammography scan. GE healthcare has presented a new technology, aiming to improve the accuracy of breast cancer diagnosis. The new technology is the SenoBright Contrast Enhanced Spectral Mammography (CESM). It provides radiologists and physicians with the ability to diagnose breast cancer with better confidence, more rapidly, and more accurately.
SenoBright Contrast Enhanced Spectral Mammography is still waiting for an approval from FDA in the United States. The new technology uses the same principle as a multiple-flash, red-eye reduction feature in a digital camera. Moreover, CESM applies x-rays at multiple energies to form two exposures; then the produced images are specifically illuminating and highlighting areas of angiogenesis. CESM differs than regular mammography in that when imaging a patient with CESM, standard iodine contrast is injected, then after two minutes, the patient starts to get imaged and the imaging process takes only 5 minutes. According to GE Healthcare, CESM images are produced in familiar mammography views, so they can be rapidly and easily compared with standard results, enhancing interpretation by other specialists.